Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer.
Johansen J, Overgaard J, Rose C, Engelholm SA, Gadeberg CC, Kjaer M, Kamby C, Juul-Christensen J, Blichert-Toft M, Overgaard M; Danish Breast Cancer Cooperative Group (DBCG) and the DBCG Radiotherapy Committee. Johansen J, et al. Among authors: rose c. Acta Oncol. 2002;41(4):369-80. doi: 10.1080/028418602760169433. Acta Oncol. 2002. PMID: 12234030 Clinical Trial.
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K. Overgaard M, et al. Among authors: rose c. N Engl J Med. 1997 Oct 2;337(14):949-55. doi: 10.1056/NEJM199710023371401. N Engl J Med. 1997. PMID: 9395428 Free article. Clinical Trial.
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT. Overgaard M, et al. Among authors: rose c. Lancet. 1999 May 15;353(9165):1641-8. doi: 10.1016/S0140-6736(98)09201-0. Lancet. 1999. PMID: 10335782 Clinical Trial.
Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial.
Overgaard M, Christensen JJ, Johansen H, Nybo-Rasmussen A, Rose C, van der Kooy P, Panduro J, Laursen F, Kjaer M, Sørensen NE, et al. Overgaard M, et al. Among authors: rose c. Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1121-4. doi: 10.1016/0360-3016(90)90214-5. Int J Radiat Oncol Biol Phys. 1990. PMID: 2254100 Clinical Trial.
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial.
Andersson M, Kamby C, Jensen MB, Mouridsen H, Ejlertsen B, Dombernowsky P, Rose C, Cold S, Overgaard M, Andersen J, Kjaer M. Andersson M, et al. Among authors: rose c. Eur J Cancer. 1999 Nov;35(12):1659-66. doi: 10.1016/s0959-8049(99)00141-0. Eur J Cancer. 1999. PMID: 10674010 Clinical Trial.
2,472 results